Novodiag® System
High multiplex technology precision engineered for simplicity, accuracy and affordability across a broad and growing menu of high- and low-plex assays.
System Highlights
A simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing. Our high multiplex technology is precision engineered for simplicity, accuracy and affordability across a broad and growing menu of high and low plex assays.
The small, quiet, stackable, fully automated platform combines easy to use functionality with molecular performance. With just a few simple steps we can deliver precise results in about an hour, bringing clinical confidence closer to patients.
Our technology is powered by 30 years of Hologic’s expertise in delivering smart solutions to complex diagnostic testing requirements. Hologic’s Novodiag is part of our world leading Molecular Scalable Solutions, designed to effortlessly help you to meet the growing demands of your lab, today and in the future.
CE marked. Not for sale in the US.
What Novodiag Tests For
- Novodiag Bacterial GE+ (High-plex Bacterial Panel – 14 targets)
- Novodiag Stool Parasites (High-plex Parasitic Panel – 26 targets)
- Novodiag COVID-19
- Novodiag RESP-4 (SARS-CoV-2, Influenza A/B, RSV)*
- Novodiag CarbaR+ (High-plex CarbaR Panel - 10 targets)
- Novodiag C. difficile
*Under development. Not for sale.
Smart simplicity in on-demand testing
Cartridge-based on-demand testing, that delivers clinical confidence in approximately an hour.
- Comprehensive screening of single or multiple pathogens in approximately 1 hour
- Ability to test up to 16 samples simultaneously optimises workflow
- Fully-automated with minimal hands-on time of <5 min
- High quality performance technology at an affordable cost
- Smart technology that combines easy to use functionality with PCR performance
- Combined PCR and microarray technologies allows high-multiplexing and syndromic approach
- High and low multiplexing capacities within the same instrument
- Dedicated support teams with expert knowledge and experience
- Targeted testing enabled through the automated ‘sample-in, result-out’ system
- Ready-to-use with no technical preparation
- User-friendly software with automated analysis, clear display of results and different levels of access
- Only one consumable that is stored at room temperature and easily disposable
Combining targeted, high multiplex and syndromic assays in one on-demand testing solution
The small, quiet, stackable, fully automated platform combines easy to use functionality with molecular performance. With just a few simple steps we can deliver precise results in about an hour, bringing clinical confidence closer to patients.
Clinical Evidence
Hologic Molecular Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.
14 bacteria detected by one assay
Wide detection of bacteria associated with gastroenteritis
26 parasites detected by one assay
Wide detection of parasites associated with gastrointestinal complications
+200 variants in one assay
Wide detection of resistance genes to carbapenem resistance
Smart simplicity in on-demand testing
- A comprehensive menu of assays for screening of antibiotic resistance, gastrointestinal, respiratory (including COVID-19) and hospital- acquired infections
- On-demand independent slots and stackable instruments for more flexibility for up to 128 tests in a 24 hour work shift
- No need for maintenance
Improve your diagnosis
In order to keep up with the pace of change within the healthcare environment, Novodiag® combines the latest technologies to improve the rendering of on-demand results. The molecular diagnostics market is striving to develop faster, more accurate, more accessible and flexible in use solutions to answer all lab's needs.
5 assays
currently available and growing
Up to 128
on-demand assays performed in a 24h work shift
Up to 16
different tests performed simultaneously
Documents
The Novodiag assays allow a simple and fast way to pinpoint patients most at risk with targeted and syndromic on-demand testing.
Related Products
